R. Colon, Drop-Out : Patients n'ayant pas complété la procédure onco-chirurgicale SSR : Survie sans récidive, ITT : Intension de traité * Taux de récidive global à 5 ans, ou à la fin du suivi si antérieur

J. P. Gérard, T. André, F. Bibeau, T. Conroy, J. L. Legoux et al., Thésorus national de cancérologie digestive: cancer du rectum, 2016.

S. Manfredi, C. Lepage, C. Hatem, O. Coatmeur, J. Faivre et al., Epidemiology and Management of Liver Metastases From Colorectal Cancer, Ann Surg. août, vol.244, issue.2, pp.254-263, 2006.

V. Lemmens, N. De-haan, H. Rutten, H. Martijn, O. Loosveld et al., Improvements in population-based survival of patients presenting with metastatic rectal cancer in the south of the Netherlands, Clin Exp Metastasis. mars, vol.28, issue.3, pp.283-90, 1992.

R. Stangl, A. Altendorf-hofmann, R. M. Charnley, and J. Scheele, Factors influencing the natural history of colorectal liver metastases, Lancet Lond Engl. 4 juin, vol.343, issue.8910, pp.1405-1415, 1994.

B. Nordlinger, M. Guiguet, J. C. Vaillant, P. Balladur, K. Boudjema et al., Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients, Association Française de Chirurgie. Cancer. 1 avr, vol.77, issue.7, pp.1254-62, 1996.

V. Vendrely, M. Terlizzi, F. Huguet, Q. Denost, L. Chiche et al., Comment traiter un cancer du rectum avec métastases hépatiques synchrones ? Une question de stratégie thérapeutique. Cancer/Radiothérapie, vol.21, pp.539-582, 2017.

E. K. Abdalla, R. Adam, A. J. Bilchik, D. Jaeck, J. Vauthey et al., Improving Resectability of Hepatic Colorectal Metastases: Expert Consensus Statement, Ann Surg Oncol, vol.13, issue.10, pp.1271-80, 2006.

B. Nordlinger, H. Sorbye, B. Glimelius, G. J. Poston, P. M. Schlag et al., Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial, The Lancet, vol.371, issue.9617, pp.1007-1016, 2008.

F. Loupakis, C. Cremolini, G. Masi, S. Lonardi, V. Zagonel et al., Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer, N Engl J Med, vol.371, issue.17, pp.1609-1627, 2014.

V. Heinemann, L. F. Weikersthal, T. Decker, A. Kiani, U. Vehling-kaiser et al., FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, Lancet Oncol. sept, vol.15, issue.10, pp.1065-75, 2014.

K. Lehmann, A. Rickenbacher, A. Weber, B. C. Pestalozzi, and P. Clavien, Chemotherapy Before Liver Resection of Colorectal Metastases: Friend or Foe?, Ann Surg. févr, vol.255, issue.2, pp.237-284, 2012.

E. Kapiteijn, C. A. Marijnen, I. D. Nagtegaal, H. Putter, W. H. Steup et al., Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer, N Engl J Med, vol.345, issue.9, pp.638-646, 2001.

D. Sebag-montefiore, R. J. Stephens, R. Steele, J. Monson, R. Grieve et al., Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. The Lancet, vol.373, pp.811-820, 2009.

W. Van-gijn, C. Marijnen, I. D. Nagtegaal, E. Kranenbarg, H. Putter et al., Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial, Lancet Oncol. juin, vol.12, issue.6, pp.575-82, 2011.

J. Bosset, L. Collette, G. Calais, L. Mineur, P. Maingon et al., Chemotherapy with preoperative radiotherapy in rectal cancer, N Engl J Med, vol.355, issue.11, pp.1114-1123, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00484917

B. Cedermark, H. Johansson, L. E. Rutqvist, and N. Wilking, The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial, Stockholm Colorectal Cancer Study Group. Cancer. 1 mai, vol.75, issue.9, pp.2269-75, 1995.

J. H. Lefevre, L. Mineur, S. Kotti, E. Rullier, P. Rouanet et al., Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6), J Clin Oncol, vol.34, issue.31, pp.3773-80, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01903754

E. Rullier, P. Rouanet, J. Tuech, A. Valverde, B. Lelong et al., Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, openlabel, multicentre, phase 3 trial. The Lancet, vol.390, pp.469-79, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01682165

E. Rullier, B. Goffre, C. Bonnel, F. Zerbib, M. Caudry et al., Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum, Ann Surg, vol.234, issue.5, pp.633-673, 2001.

C. P. Probst, A. Z. Becerra, C. T. Aquina, M. A. Tejani, S. D. Wexner et al., Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation, J Am Coll Surg. août, vol.221, issue.2, pp.430-470, 2015.

R. Adam, A. De-gramont, J. Figueras, N. Kokudo, F. Kunstlinger et al., Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus, Cancer Treat Rev, vol.41, issue.9, pp.729-770, 2015.

N. C. Buchs, F. Ris, P. E. Majno, A. Andres, W. Cacheux et al., Rectal Outcomes After a Liver-First Treatment of Patients with Stage IV Rectal Cancer, Ann Surg Oncol. mars, vol.22, issue.3, pp.931-938, 2015.

R. Martin, P. Paty, Y. Fong, A. Grace, A. Cohen et al., Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis, J Am Coll Surg. août, vol.197, issue.2, pp.233-274, 2003.

S. K. Reddy, T. M. Pawlik, D. Zorzi, A. L. Gleisner, D. Ribero et al., Simultaneous Resections of Colorectal Cancer and Synchronous Liver Metastases: A Multi-institutional Analysis, Ann Surg Oncol, vol.14, issue.12, pp.3481-91, 2007.

E. Cotte, L. Villeneuve, G. Passot, G. Boschetti, S. Bin-dorel et al., GRECCAR 8: impact on survival of the primary tumor resection in rectal cancer with unresectable synchronous metastasis: a randomized multicentre study, BMC Cancer. 12 févr, vol.15, p.47, 2015.

G. Mentha, P. E. Majno, A. Andres, L. Rubbia-brandt, P. Morel et al., Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary, Br J Surg. juill, vol.93, issue.7, pp.872-880, 2006.

N. Ayez, J. Burger, A. E. Van-der-pool, A. Eggermont, D. J. Grunhagen et al., Approach in Patients With Locally Advanced Rectal Cancer and Synchronous Liver Metastases, Dis Colon Rectum. mars, vol.56, issue.3, pp.281-288, 2013.

M. E. Kelly, G. Spolverato, G. N. Lê, M. N. Mavros, F. Doyle et al., Synchronous colorectal liver metastasis: a network meta-analysis review comparing classical, combined, and liver-first surgical strategies, J Surg Oncol. mars, vol.111, issue.3, pp.341-51, 2015.

D. Collins and H. Chua, Contemporary surgical management of synchronous colorectal liver metastases, vol.6, p.598, 2017.

L. Viganò, G. Torzilli, M. Cimino, K. Imai, E. Vibert et al., Drop-out between the two liver resections of two-stage hepatectomy. Patient selection or loss of chance?, Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. sept, vol.42, issue.9, pp.1385-93, 2016.

J. M. Phelip, B. O. Benhaim-l, and C. N. Tournigan-c, Thésorus national de cancérologie digestive: cancer colorectal métastatique, 2018.

P. Quirke, R. Steele, J. Monson, R. Grieve, S. Khanna et al., Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCICCTG CO16 randomised clinical trial, Lancet Lond Engl. 7 mars, vol.373, issue.9666, pp.821-829, 2009.

D. Vandeweyer, E. L. Neo, J. Chen, G. J. Maddern, T. G. Wilson et al., Influence of resection margin on survival in hepatic resections for colorectal liver metastases, HPB. sept, vol.11, issue.6, pp.499-504, 2009.

S. Benoist, A. Brouquet, C. Penna, C. Julié, E. Hajjam et al., Complete response of colorectal liver metastases after chemotherapy: does it mean cure?, J Clin Oncol Off J Am Soc Clin Oncol. 20 août, vol.24, issue.24, pp.3939-3984, 2006.

D. A. Bischof, B. M. Clary, S. K. Maithel, and T. M. Pawlik, Surgical management of disappearing colorectal liver metastases, Br J Surg. oct, vol.100, issue.11, pp.1414-1434, 2013.

K. Kuhlmann, J. Van-hilst, S. Fisher, and G. Poston, Management of disappearing colorectal liver metastases, Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. déc, vol.42, issue.12, pp.1798-805, 2016.

L. Rubbia-brandt, E. Giostra, C. Brezault, A. D. Roth, A. Andres et al., Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery, Ann Oncol Off J Eur Soc Med Oncol. févr, vol.18, issue.2, pp.299-304, 2007.

P. Rouanet, A. Mourregot, C. C. Azar, S. Carrere, M. Gutowski et al., Transanal endoscopic proctectomy: an innovative procedure for difficult resection of rectal tumors in men with narrow pelvis, Dis Colon Rectum. avr, vol.56, issue.4, pp.408-423, 2013.

A. M. Lacy, M. M. Tasende, S. Delgado, M. Fernandez-hevia, M. Jimenez et al., Transanal Total Mesorectal Excision for Rectal Cancer: Outcomes after 140 Patients, J Am Coll Surg. août, vol.221, issue.2, pp.415-438, 2015.

J. Tuech, M. Karoui, B. Lelong, C. De-chaisemartin, V. Bridoux et al., A step toward NOTES total mesorectal excision for rectal cancer: endoscopic transanal proctectomy, Ann Surg. févr, vol.261, issue.2, pp.228-261, 2015.

M. Fernández-hevia, S. Delgado, A. Castells, M. Tasende, D. Momblan et al., Transanal total mesorectal excision in rectal cancer: short-term outcomes in comparison with laparoscopic surgery, Ann Surg. févr, vol.261, issue.2, pp.221-228, 2015.

E. Rullier, Q. Denost, V. Vendrely, A. Rullier, and C. Laurent, Low Rectal Cancer: Classification and Standardization of Surgery, Dis Colon Rectum. mai, vol.56, issue.5, pp.560-567, 2013.

M. Maas, P. J. Nelemans, V. Valentini, P. Das, C. Rödel et al., Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data, Lancet Oncol. sept, vol.11, issue.9, pp.835-879, 2010.

A. Habr-gama, R. O. Perez, W. Nadalin, J. Sabbaga, U. Ribeiro et al., Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results, Ann Surg, vol.240, issue.4, pp.717-718, 2004.

D. Dindo, N. Demartines, and P. Clavien, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann Surg. août, vol.240, issue.2, pp.205-218, 2004.

B. Lelong, T. Bege, B. Esterni, J. Guiramand, O. Turrini et al., ShortTerm Outcome After Laparoscopic or Open Restorative Mesorectal Excision for Rectal Cancer: A Comparative Cohort Study: Dis Colon Rectum, févr, vol.50, issue.2, pp.176-83, 2007.

H. Salvador-rosés, S. López-ben, M. Casellas-robert, P. Planellas, N. Gómezromeu et al., Oncological strategies for locally advanced rectal cancer with synchronous liver metastases, interval strategy versus rectum first strategy: a comparison of short-term outcomes, Clin Transl Oncol, vol.22, issue.2017

. Disponible,

K. J. Labori, M. G. Guren, K. W. Brudvik, B. I. Røsok, A. Waage et al., Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival, Colorectal Dis. août, vol.19, issue.8, pp.731-739, 2017.

D. 'hondt, M. Lucidi, V. Vermeiren, K. Van-den-bossche, B. Donckier et al., The interval approach: an adaptation of the liver-first approach to treat synchronous liver metastases from rectal cancer, World J Surg Oncol, vol.15, issue.1, 2017.

S. Jegatheeswaran, J. M. Mason, H. C. Hancock, and A. K. Siriwardena, The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systematic review, JAMA Surg. avr, vol.148, issue.4, pp.385-91, 2013.

A. K. Siriwardena, A. Chan, A. M. Ignatowicz, and J. M. Mason, CoSMIC study collaborators. Colorectal cancer with Synchronous liver-limited Metastases: the protocol of an Inception Cohort study (CoSMIC), BMJ Open, vol.09, issue.6, p.15018, 2017.